Overview

Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase 1I Study to Investigate the Safety, Efficacy, and Pharmacokinetic Profile of Twice-Daily DNB-001 in Previously Untreated Patients with intraocular Hypertension
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Danube Pharmaceuticals, Inc.